| Fund Name | Location |
| Avaloq Ventures | Switzerland, Zürich, Zurich |
| Beijing Gaoxin Chengzhang Chuangtou | Beijing, Beijing, China |
| Big Hit Music | Seoul, Seoul-t'ukpyolsi, South Korea |
| Cresud Sacifya | Argentina, Buenos Aires, Moreno |
| Fonterra Co-operative Group | Auckland, Auckland, New Zealand |
| Grand Angels | Holland, Michigan, United States |
| Millry Communications | Alabama, Millry, United States |
| Pacific Rim Partners | California, San Francisco, United States |
| Total Access Fund | Manchester, New Hampshire, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Wave | $3M | 09 May 2023 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
Sweet Spot | $8M | 27 Jan 2023 | South Korea, Gyeonggi-do, South Korea | ||
Mathpresso | 13 Dec 2022 | South Korea, Gyeonggi-do, South Korea | |||
Break & Company | $4M | 19 Aug 2022 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
Rael | $35M | 25 May 2022 | Los Angeles, California, United States | ||
Wave | $4M | 06 May 2022 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
Genome Insight | $23M | 30 Apr 2022 | La Jolla, California, United States | ||
Cipherome | $16K | 14 Feb 2022 | San Jose, California, United States | ||
Kokoji | $5M | 23 Dec 2021 | Seoul, Seoul-t'ukpyolsi, South Korea |
– Speclipse is a Seoul, South Korea-based developer of laser spectroscopic and AI-based medical diagnosis technologies.
– The company raised $7.7m in funding.
– The round was led by Signite Partners with participation from BNH Investment, Shinhan Capital, MiCo and MiCoBioMed.
– The new investment will be used to accelerate growth, expand operations and its business reach.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Wave | $3M | 09 May 2023 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
Sweet Spot | $8M | 27 Jan 2023 | South Korea, Gyeonggi-do, South Korea | ||
Mathpresso | 13 Dec 2022 | South Korea, Gyeonggi-do, South Korea | |||
Break & Company | $4M | 19 Aug 2022 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
Rael | $35M | 25 May 2022 | Los Angeles, California, United States | ||
Wave | $4M | 06 May 2022 | Seoul, Seoul-t'ukpyolsi, South Korea | ||
Genome Insight | $23M | 30 Apr 2022 | La Jolla, California, United States | ||
Cipherome | $16K | 14 Feb 2022 | San Jose, California, United States | ||
Kokoji | $5M | 23 Dec 2021 | Seoul, Seoul-t'ukpyolsi, South Korea |
